Insights into the BZKF BORN-Project – Interview with Dr. Mandy Wahlbuhl-Becker
The Bavarian Oncological Radiology Network (BORN) is enhancing cancer diagnostics in Bavaria through standardized imaging and structured reporting.
…
The Bavarian Oncological Radiology Network – Standardized Imaging for Improved Cancer Care: Interview with Dr. Mandy Wahlbuhl-Becker
The Bavarian Oncological Radiology Network (BORN) aims to support patients and medical professionals across Bavaria by standardizing imaging…
RACOON-RESCUE is Advancing Pediatric Non-Hodgkin Lymphoma Care
Pediatric Non-Hodgkin Lymphoma (NHL) is the fourth most common tumor in children and adolescents, yet its radiological methods lack standardization,…
University Hospital Tübingen: Neuro-Oncological Imaging with Deep Learning Reconstruction (DLR)
A recent study conducted by the University Hospital of Tübingen investigated the potential of deep learning reconstruction (DLR) in magnetic resonance…
Project RACOON-RESCUE: Advancing Diagnosis and Treatment for Pediatric Non-Hodgkin Lymphoma
Pediatric Non-Hodgkin Lymphoma (NHL), a type of lymph node cancer, is the fourth most common tumor in children and adolescents. Radiological…
Streamline Prostate Cancer Screenings with Prostate.Carcinoma.ai in mint Lesion
The Prostate.Carcinoma.ai plug-in, developed by our partner FUSE-AI, is a powerful addition to mint Lesion, designed specifically to enhance prostate…
Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer
In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…
University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer
A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…
Developing Standardized Reporting Templates for Sarcomas: Insights from Prof. Dr. Wolfgang Kunz
Sarcomas are a rare and heterogeneous group of malignant tumors that pose significant challenges in both diagnosis and treatment. Within the framework…
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.
